OCULAR THERAPEUTIX, INC·4

Feb 3, 6:27 PM ET

Goldstein Michael H. 4

4 · OCULAR THERAPEUTIX, INC · Filed Feb 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-30
Goldstein Michael H.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-30+215,000215,000 total
    Exercise: $4.39Exp: 2020-01-29Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    a4.xmlPrimary

    4